Dr. Erik Mikaitis provides executive leadership to advance the health system’s strategic imperatives and ensure the provision of high-quality care and services, in collaboration with CCH’s medical and business leaders. He was appointed as Chief Executive Officer in October 2024, after serving in the Interim CEO role since November 2023.

Since joining CCH as Chief Quality Officer in 2022, Dr. Mikaitis has served as a champion of quality and compliance, implementing evidence-based processes to improve the delivery of care across the system. He implemented numerous quality initiatives to improve patient outcomes across CCH, including a new multifaceted strategy deployment system that resulted in significant improvement in the system’s sepsis prevention and treatment. Dr. Mikaitis enhanced the system’s quality and safety dashboard and deployed a regulatory readiness program. In this role, he also provided guidance for utilization management, coding and documentation, and hospital throughput.

Dr. Mikaitis previously served as Vice President and Chief Medical Officer for Franciscan Health Crown Point, where, among other duties, he led the development of safety protocols and processes during the COVID-19 pandemic and developed a new dashboard for communicating quality improvements to the board. Prior to assuming that role, Dr. Mikaitis served as Medical Director of the Franciscan Health Accountable Care Organization in the northern Indiana and south suburban Chicago regions.

A board-certified Internal Medicine Physician, Dr. Mikaitis earned a Bachelor of Science from the University of Illinois at Chicago, a Master of Business Administration from DePaul University, and a medical degree from Ross University.